H-Gly-Pro-OH

CAS No. 704-15-4

H-Gly-Pro-OH( Glycyl proline | Glycyl-L-proline )

Catalog No. M20287 CAS No. 704-15-4

H-Gly-Pro-OH is a dipeptide composed of glycine and proline and is an end product of collagen metabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 39 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    H-Gly-Pro-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    H-Gly-Pro-OH is a dipeptide composed of glycine and proline and is an end product of collagen metabolism.
  • Description
    H-Gly-Pro-OH is a dipeptide composed of glycine and proline and is an end product of collagen metabolism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Glycyl proline | Glycyl-L-proline
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    704-15-4
  • Formula Weight
    172.18
  • Molecular Formula
    C7H12N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    Water:34 mg/mL (197.46 mM)
  • SMILES
    NCC(=O)N1CCC[C@H]1C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Le J Perier C Peyroche S et al. Urine glycyl-L-proline increase and skin trophicity[J]. Amino Acids (Vienna) 1999 17(3):315-322.
molnova catalog
related products
  • Glycerol

    Glycerol or glycerin is a colourless odourless viscous liquid that is sweet-tasting and mostly non-toxic. It is widely used in the food industry as a sweetener and humectant and in pharmaceutical formulations.

  • 1-Methyladenosine

    1-Methyladenosine (M1A) belongs to the class of organic compounds known as purine nucleosides.

  • Phenylacetic acid

    Phenyl acetate (or phenylacetate) is a carboxylic acid ester that has been found in the biofluids of patients with nephritis and/or hepatitis as well as patients with phenylketonuria (PKU) an inborn error of metabolism. Excess phenylalanine in the body can be disposed of through a transamination process leading to the production of phenylpyruvate.